Clinical NewsCorrectionOct 4, 2004FacebookLinkedInX (Twitter)Pinterest Add us as a preferred source on Google In our last Letter from the Editor, we incorrectly reported the name of Schering's Primovist MRI contrast agent in our story about European Union approval of the product.FacebookLinkedInX (Twitter)Pinterest Add us as a preferred source on Google Latest in Clinical NewsPhilips, U of Washington explore AI for non-contrast breast MRIJuly 9, 2026Blue Earth, UCL dose first patient in Ac-225 PSMA prostate trialJuly 9, 2026AI ultrasound model accurately estimates gestational ageJuly 9, 2026Leo Cancer Care nets $65M to deploy proton therapy systemJuly 8, 2026Related StoriesBreastWhen push comes to shove: Addressing compression in mammographyBreastPreparation key to surviving MQSA inspectionsClinical NewsBiochem enters ultrasound domain in fetal screeningBreastBreast Imaging: The Requisites
